The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fatigue in long-term survivors with ovarian cancer: Results of Expression VI – Carolin meets HANNA – Holistic analysis of Long-term survival with ovarian cancer—The international NOGGO, ENGOT and GCIG survey.
 
Hannah Woopen
Travel, Accommodations, Expenses - Medac
 
Maren Keller
No Relationships to Disclose
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche Pharma AG; Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; ImmunoGen; MSD; Roche Pharma AG; Takeda; Tesaro
Research Funding - Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD; Roche Pharma AG
 
Dario Zocholl
Travel, Accommodations, Expenses - Merck KGaA
 
Petra Krabisch
No Relationships to Disclose
 
Tamara Boxler
No Relationships to Disclose
 
Maria Pilar Barretina-Ginesta
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; PharmaMar; Roche; Tesaro
 
Cesar Mendiola
Research Funding - Fundación Investigation H12 Octubre (Inst)
Travel, Accommodations, Expenses - Roche
 
Judith Lafleur
No Relationships to Disclose
 
Daniel Uwe Reimer
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - PharmaMar
 
Viola A. Heinzelmann-Schwarz
No Relationships to Disclose
 
Eleftherios Pierre Samartzis
No Relationships to Disclose
 
Mehmet Ali Vardar
No Relationships to Disclose
 
Cagatay Taskiran
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Carrick Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Medical University of Vienna (Inst); Millennium (Inst); MSD Belgium (Inst); Octimet (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Els Van Nieuwenhuysen
Travel, Accommodations, Expenses - Roche
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novocure; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro